Alembic Pharmaceuticals Limited recalls Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Form…
- Recall date
- June 10, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1341-2020
- FDA classification
- Class II
- Brand / firm
- Alembic Pharmaceuticals Limited
- Sold / distributed
- Nationwide in the U.S.
Why it was recalled
Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 389350, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA, NDC 62332-097-30.
Get recall alerts
Free email alert whenever Alembic Pharmaceuticals Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Alembic Pharmaceuticals Limited